Ponatinib 30mg tablets

SNOMED code
34819011000001103
Active compound
Ponatinib
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 tablet, tablet
Ingredients
Ponatinib hydrochloride, ID: 703796003 — 30 mg based on base substance
Form & Route
tablet.oral
Oral tablet, Oral
Controlled drug
No Controlled Drug Status

Products

Ponatinib 30mg tablets (Incyte Biosciences UK Ltd)

Ponatinib 30mg tablets

SNOMED code
42790711000001103
Supplier
Incyte Biosciences UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Oral
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Ponatinib 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet
42790911000001101   ref. pack
💯 Available

Legal category: POM
07640159434160

End: 7640159434160
NHS Indicative Price
  £5,050
previously: £4,115
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Discount not deducted - automatic
Iclusig 30mg tablets (Incyte Biosciences UK Ltd)

Iclusig 30mg tablets

SNOMED code
34794011000001101
Supplier
Incyte Biosciences UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Oral
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet
34794111000001100   ref. pack
Discontinued


Legal category: POM
7640159430841
NHS Indicative Price
£5,050
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Discount not deducted - automatic

Reference packs

Ponatinib 30mg tablets 30 tablet
SNOMED code
34793911000001104
Quantity and unit
30 tablet
Packs